Product ID |
Product Name |
CAS# |
Purity |
Y1253770 |
KIN1408 |
1903800-11-2 |
98% |
Y3190194 |
3-hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide |
192883-14-0 |
98% |
Y3190195 |
5Z-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-2,4-thiazolidinedione |
870554-67-9 |
95% |
Y3104906 |
N-methyl-N-[[3-(4-pyridinyl)phenyl]methyl]-,2,2,2-trifluoro-1-(trifluoromethyl)ethylester-carbamicacid |
1416133-88-4 |
98% |
Y1338877 |
3,4-dihydro-2-methyl-1,1-dimethylethylester-2H-pyrrole-2-carboxylicacid-1-oxide |
387334-31-8 |
98% |
Y3151513 |
4-[[[5,6-dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]-benzoicacid |
182135-66-6 |
99% |
Y3292938 |
guanylyl-(3'5')-3'-guanylicacid,cyclicnucleotide,disodiumsalt |
2222132-40-1 |
99% |
Y3192851 |
N-[4-[4-[(2-oxiranylmethyl)sulfonyl]phenoxy]phenyl]-methanesulfonamide |
869577-51-5 |
98% |
Y3151654 |
3-bromo-N-[3-[(1,1-dimethylethyl)amino]propyl]-benzamide,2Z-butenedioate |
2173992-60-2 |
95% |
Y3291764 |
7-hydroxy-3-(4-hydroxyphenyl-2,3,5,6-d4)-4H-1-benzopyran-4-one |
1219803-57-2 |
98% |
Y1253771 |
2,3-dihydro-5,6-dimethoxy-2[[1-(phenylmethyl-d2)-4-piperidinyl]methyl-d2]-1H-inden-1-one,monohydrochloride |
1219798-88-5 |
99% D |
Y3151434 |
5-((3,4-dimethoxyphenethyl)(methyl-d3)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile,monohydrochloride |
2714485-49-9 |
99.57% |
Y3287254 |
ethyl3-(2-(((4-(N-(((hexyl-d13)oxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
2749293-92-1 |
98% |
Y3291235 |
3-hydroxy-2-nonyl-4(1H)-quinolinone |
1259944-03-0 |
98% |
Y3264930 |
(3ß,20E)-24-Norchola-5,20(22)-diene-3,23-diol |
53495-21-9 |
95% |
Y1253442 |
3-Methyltoxoflavin |
32502-62-8 |
99% |
Y1253542 |
F 16915 |
92510-91-3 |
99% |
Y1253405 |
A-395 |
2089148-72-9 |
99% |
Y3286406 |
KRN5 |
1800465-47-7 |
98% |
Y3310666 |
HAE |
64111-99-5 |
99% |
Y1253444 |
FR194738 free base |
204067-45-8 |
99% |
Y3309955 |
11ß-HSD1-IN-1 |
1203956-47-1 |
99% |
Y1249151 |
MM 07 |
1876450-21-3 |
95% |
Y3104982 |
Carboxy pyridostatin trifluoroacetate salt |
2444713-88-4 |
99% |
Y3310167 |
Ac-Leu-Arg-AMC |
929621-79-4 |
99.26% |
Y1257761 |
Derazantinib Racemate |
2309668-44-6 |
99% |
Y3316985 |
Cenobamate S-Enantiomer |
913088-81-0 |
95%+ |
Y1249076 |
Edicotinib |
1142363-52-7 |
97% |
Y1249152 |
ATP-Red 1 |
1847485-97-5 |
98% |
Y1236268 |
Abiraterone metabolite 1 |
1940176-03-3 |
99% |
Y3306119 |
HAEGT |
852155-81-8 |
98% |
Y1240604 |
PSMA-617 |
1702967-37-0 |
99% |
Y1266882 |
OTX008 |
286936-40-1 |
98% |
Y1240686 |
GSK1379725A |
1802251-00-8 |
98% |
Y1236270 |
NVP-HDM201 R Enantiomer |
1448867-42-2 |
99% |
Y3113209 |
ZINC03129319 |
1777807-64-3 |
95% |
Y3113204 |
ß-Apo-13-carotenone |
17974-57-1 |
96% |
Y1266878 |
GLX351322 |
835598-94-2 |
95% |
Y1343995 |
Ac-Gly-BoroPro |
886992-99-0 |
98% |
Y3113208 |
Lith-O-Asp |
881179-02-8 |
98% |
Y1266952 |
WNK-IN-11 |
2123489-30-3 |
98% |
Y1240689 |
Avoralstat |
918407-35-9 |
98% |
Y1240690 |
Neurotoxin Inhibitor |
951571-70-3 |
99% |
Y1240691 |
THK5351 |
1707147-26-9 |
98% |
Y1240645 |
SHIN1 |
2146095-85-2 |
98% |
Y1236338 |
TB500 |
885340-08-9 |
98% |
Y1240647 |
JAK2 JH2 Tracer |
2101955-00-2 |
98% |
Y1236273 |
N-deacetylated BMS-202 |
2310135-18-1 |
98% |
Y1236274 |
NucPE1 |
1404091-23-1 |
98% |
Y1266954 |
TES-1025 |
1883602-21-8 |
98% |
Y1236339 |
EC330 |
2016795-77-8 |
98% |
Y1266885 |
ISA-2011B |
1395347-24-6 |
99% |
Y3216169 |
BETd-260 |
2093388-62-4 |
95% |
Y1266956 |
IACS-9571 Hydrochloride |
2319611-93-1 |
99% |
Y1240737 |
ORY-1001(trans) |
1431303-72-8 |
98% |
Y1266886 |
GSK-LSD1 Dihydrochloride |
2102933-95-7 |
98% |
Y1266887 |
BCI-121 |
432529-82-3 |
98% |
Y1266960 |
SIRT5 inhibitor |
2166487-21-2 |
98% |
Y1240649 |
SRI-011381 hydrochloride |
2070014-88-7 |
99% |
Y1236340 |
EMT inhibitor-1 |
1638526-21-2 |
99% |
Y1266961 |
MRT-83 |
1263131-92-5 |
99% |
Y1236298 |
UT-155 |
2031161-35-8 |
99% |
Y1344098 |
Vactosertib Hydrochloride |
1352610-25-3 |
98% |
Y1266889 |
LY3200882 |
1898283-02-7 |
99% |
Y3310242 |
ELN 318463 racemate |
851599-82-1 |
99% |
Y3293379 |
RU-SKI 43 hydrochloride |
1782573-67-4 |
99% |
Y1262580 |
Ningetinib |
1394820-69-9 |
98% |
Y1266932 |
PRN694 |
1575818-46-0 |
99% |
Y3305034 |
KDR-in-4 |
408502-06-7 |
97% |
Y3293504 |
Pz-1 |
1800505-64-9 |
99% |
Y1266913 |
eCF506 |
1914078-41-3 |
99% |
Y1266850 |
KX2-391 Mesylate |
1080645-95-9 |
99% |
Y1267012 |
DDR Inhibitor |
1644069-80-6 |
99% |
Y1262523 |
cFMS-IN-2 |
791587-67-2 |
99% |
Y1266851 |
PROTAC Linker 4 |
1799506-30-1 |
95% |
Y1343778 |
FLT3-IN-1 |
1472797-69-5 |
98% |
Y1262542 |
Pyrotinib dimaleate |
1397922-61-0 |
99% |
Y1262543 |
tarloxotinib bromide |
1636180-98-7 |
99% |
Y1262525 |
HS-10296 hydrochloride |
2134096-03-8 |
98% |
Y1236324 |
Btk inhibitor 2 |
1558036-85-3 |
99% |
Y1266852 |
Ensartinib hydrochloride |
2137030-98-7 |
99% |
Y1262618 |
JH-VIII-157-02 |
1639422-97-1 |
99% |
Y1258292 |
SM 16 |
614749-78-9 |
97% |
Y3192733 |
PROTAC CDK9 Degrader-1 |
2118356-96-8 |
99% |
Y3290633 |
AT6 |
2098836-50-9 |
99% |
Y3188503 |
Protein degrader 1 TFA |
1631137-51-3 |
99% |
D762907 |
BF738735 |
1436383-95-7 |
95% |
Y1236325 |
E3 ligase Ligand-Linker Conjugates 3 |
2101200-09-1 |
95% |
Y1258296 |
E3 Ligase Ligand-Linker Conjugates 1 |
2097938-44-6 |
95% |
Y1335542 |
E3 ligase Ligand-Linker Conjugates 17 |
1950635-16-1 |
98% |
Y1236326 |
E3 ligase Ligand-Linker Conjugates 14 |
1957236-21-3 |
98% |
Y1335587 |
E3 ligase Ligand-Linker Conjugates 15 |
2308035-51-8 |
98% |
Y1266855 |
E3 Ligase Ligand-Linker Conjugates 25 Trifluoroacetate |
1950635-14-9 |
97% |
Y1258297 |
E3 ligase Ligand-Linker Conjugates 10 |
1835705-57-1 |
98% |
Y1236266 |
E3 Ligase Ligand-Linker Conjugates 24 TFA |
1957235-75-4 |
97% |
Y3318523 |
PI3Kα/mTOR-IN-1 |
1013098-90-2 |
99% |
Y1267013 |
PQR620 |
1927857-56-4 |
98% |
Y1240684 |
K-80003 |
1292821-90-9 |
98% |
Y1258299 |
Edasalonexent |
1204317-86-1 |
98% |
Y1240603 |
IKK-IN-1 |
406211-06-1 |
95% |